This statistic shows the market capitalization of select significant gene and cell therapy companies from several countries, as of March 31, 2023. The selection excludes large companies involved in cell and gene therapy. The market capitalization of Bluebird Bio, an oncology gene therapy company, stood at some 320 million U.S. dollars. Many of this smaller companies saw a decline in market capitalization over the last few years.
Market capitalization of selected gene and cell therapy companies worldwide as of 2023
(in billion U.S. dollars)
This statistic does not include big pharma companies involved in cell and gene therapies, like Bayer, BMS, Novartis, Roche, etc. Additionally, it does not include companies focused on CRISPR/Cas9.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Statista. (March 31, 2023). Market capitalization of selected gene and cell therapy companies worldwide as of 2023 (in billion U.S. dollars) [Graph]. In Statista. Retrieved November 21, 2024, from https://www.statista.com/statistics/827652/gene-and-cell-therapy-companies-market-cap/
Statista. "Market capitalization of selected gene and cell therapy companies worldwide as of 2023 (in billion U.S. dollars)." Chart. March 31, 2023. Statista. Accessed November 21, 2024. https://www.statista.com/statistics/827652/gene-and-cell-therapy-companies-market-cap/
Statista. (2023). Market capitalization of selected gene and cell therapy companies worldwide as of 2023 (in billion U.S. dollars). Statista. Statista Inc.. Accessed: November 21, 2024. https://www.statista.com/statistics/827652/gene-and-cell-therapy-companies-market-cap/
Statista. "Market Capitalization of Selected Gene and Cell Therapy Companies Worldwide as of 2023 (in Billion U.S. Dollars)." Statista, Statista Inc., 31 Mar 2023, https://www.statista.com/statistics/827652/gene-and-cell-therapy-companies-market-cap/
Statista, Market capitalization of selected gene and cell therapy companies worldwide as of 2023 (in billion U.S. dollars) Statista, https://www.statista.com/statistics/827652/gene-and-cell-therapy-companies-market-cap/ (last visited November 21, 2024)
Market capitalization of selected gene and cell therapy companies worldwide as of 2023 (in billion U.S. dollars) [Graph], Statista, March 31, 2023. [Online]. Available: https://www.statista.com/statistics/827652/gene-and-cell-therapy-companies-market-cap/
